• Type:

Why so much money is invested in cell therapies ?

Play
Involved in the acquitision of Bluerock Therapeutics by Bayer in 2019, as Investment Director at Leaps, Alasdair Thong is a Venture Partner in several international VC funds. Given its specific expertise in stem cell therapies, we asked him why funding rounds and IPOs in the field have skyrocketed in 2020.

Reviews for Why so much money is invested in cell therapies ?

There are currently no reviews for Why so much money is invested in cell therapies ?
Scroll to top